Delivering Chemo Directly Into Brain Tumors Shows Promise
... 3 percent of patients diagnosed with a malignant glioma survive five years or more, according to ... Even when there's no tumor visible, microscopic glioma cells usually remain that eventually regrow, ... been shown to be effective in killing malignant glioma cells, but delivering enough of it through the ...Brain tumor treatment may increase number of cancer stem-like cells
... ABCG2, a protein linked with drug resistance, in glioma cancer stem-like cells. "ABC proteins are ... human glioblastomas. "Because the SP phenotype in glioma cancer stem-like cells is mainly mediated by ... although not by itself oncogenic, is a marker for glioma stem-like cells. Further, the researchers ...Cancer-killing viruses influence tumor blood-vessel growth
... study, Kaur and her colleagues implanted human glioma cells into rodents with a working immune system, ... in CYR61 gene activity using several different glioma cell lines and glioma cells from patients, and several strains of ...RTOG Study Likely Treatment Option for Brain Tumor Patients like Sen. Kennedy
... patients with newly diagnosed malignant glioma is a possible consideration for Sen. Edward ... (ACR), is enrolling approximately 1153 malignant glioma patients at 217 sites throughout the United ... practice) will improve the outcome for malignant glioma patients and what effects, if any, the longer ...Ted Kennedy Released From Hospital
... the cause of the seizure as a malignant glioma in the left parietal lobe. The usual course of ... not possible or not desirable. "But malignant glioma are infiltrative tumors," added Friedman, who's ... The National Library of Medicine has more on glioma . SOURCES: Deepa ...Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells
... induced cell death . Although not every glioma cell line has an activated Ras pathway, Ras ... killing was seen in 19 of 24 established human glioma cell lines tested. Reovirus also infected and killed all nine of nine primary glioma cultures taken from brain tumor surgical ...Other highlights in the Oct. 30 JNCI
... and colleagues discuss current therapies for glioma that affect communication between tumor cells and ... they are less likely to develop resistance than glioma cells. A better understanding of the ... genetically stable normal cells that surround the glioma rather than the genetically unstable tumor cells ...Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
... to initiate a Phase III clinical study in glioma in the second half of 2008. BPH is a common ... completed a Phase II clinical trial of Litx in glioma and plans to initiate a Phase III trial in glioma during the second half of 2008. LSO has widened ...Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
... Board #J13; GU General Poster Session, May 31, 2:00 p.m.-6:00 p.m. glioma Fiveash J, et al. NABT-0702: A phase II study of AT-101 in recurrent ... malignancies (with Rituxan(R)), small cell lung cancer (with Hycamtin(R)), glioma (with Temodar(R), +/- chemoradiotherapy [XRT]) and esophageal cancer (with ...Light Sciences Oncology Raises $40.1 Million in Series C Financing
... the liver, the company has completed a Phase II clinical trial of Litx in glioma and plans to initiate a Phase III trial in glioma during the second half of 2008. LSO has widened the scope of potential ...St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors
... The improved survival of children under 3 years old with diffuse pontine glioma compared to older children suggests that the biological properties of this ... children under 3 years old who have a brain tumor called diffuse pontine glioma (DPG) appear to have a better outcome than older children with the same ...Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
... Wafer is indicated in patients with newly diagnosed high-grade malignant glioma as an adjunct to surgery and radiation. Gliadel is also indicated in ... of the components of Gliadel. Patients undergoing craniotomy for malignant glioma and implantation of Gliadel should be monitored closely for complications ...Cancer Research 'David' Hopes to Slay 'Cancer Goliath'
... lung, spine, pancreas, prostate, ovary, and stomach. In addition, some effectiveness was seen in an instance of lymphoid leukemia, and one of a glioma of the ocular nerve. These tests preceded his more recent death due to an unfortunate accident. As a small Foundation hard hit by the untimely ...Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
... A recent article published in Neuro-Oncology (Lamborn et al, 2008) examined six-month progression free survival as a predictor of overall survival in glioma patients. The article included data from 597 adult patients with recurrent high-grade gliomas that enrolled in Phase II trial protocols collected by ...Computer model predicts brain tumor growth and evolution
... suffering from this type of tumor, a malignant glioma of the brain. Details of the research were ... game. The result: A three-dimensional matrix of a glioma that can be adjusted to see what its growth stage ... validated their computational model with glioma specimens. Bearer studied about 40 different ...Lithium may help radiation target cancer, spare healthy tissue
... NHEJ pathway. However, none of these effects were observed in malignant glioma (brain tumor) cells, presumably because cancer cells generally utilize a ... the safety and feasibility of lithium treatment in patients with low-grade glioma or brain metastases from small cell lung cancer. "Right now, the ...TGen researchers discover possible way to block the spread of deadly brain tumors
... meant a fast maturation of NHERF-1 from a candidate gene associated with glioma invasion to positioning it as having a verified role in contributing to ... said. In the study, depletion of NHERF-1 stopped the migration of glioma brain cancer cells, she said. "These results suggest that NHERF-1 plays ...Engineers create intelligent molecules that seek-and-destroy diseased cells
... where it is not doing what we would like it to do," Smolke said. She hopes to translate her technologies into intelligent cellular therapeutics for glioma patients in the next five years. "That's a very optimistic view," she said. "But so far things have been moving quickly." The broader implications ...Veterinary college researcher studying brain tumors in people and animals
... and are currently enrolling animals from around the region that have been positively diagnosed with a brain mass consistent with the appearance of a glioma on magnetic resonance imaging (MRI). The researchers will be studying tissue samples from affected animals in search of these proteins that are ...Cancer stem cells linked to radiation resistance
... The researchers first measured the number of glioma stem cells present in the original tissue and ... observed a roughly fourfold jump in the number of glioma stem cells present in the tumor tissue following ... cells, DNA, the researchers hypothesized that the glioma stem cells survive and multiply by somehow fixing ...Targeted virus compels cancer cells to eat themselves
... The modified adenovirus homed in on malignant glioma cells in mice and induced enough ... promoter regulated adenovirus) infected the glioma cells and induced autophagy by inactivating a ... volume among mice with subcutaneous malignant glioma that got hTERT-Ad and those that received a ...Unique dual target specificity of kinase inhibitor key for success against cancer
... of a broad range of lethal malignant glioma cells in vitro and in vivo. The findings, ... critical for growth and progression of malignant glioma cells. UCSF colleagues Zachary Knight and Kevan ... Fan in the Weiss lab screened these agents in glioma cell lines. One compound, PI-103, uniquely and ...Marrow-derived stem cells deliver new cytokine to kill brain tumor cells, offer protection
... cells ?have the ability to target and track glioma cells in the brain, even as they migrate. The ... immune responses ?to track down and destroy glioma cells. In 2002, the scientists reported that ... anti-tumor response that tracks to migrating glioma islands and offers long-term protection ?all of ...Data for Oncothyreon's PX-12 and PX-866 presented at AACR Annual Meeting
... for assessing molecular responses to PX-866 in a glioma tumor model. Results show that PX-866 treatment ... has multiple anti-cancer activities in glioma cells and suggest that MRS may have utility in ... of targets that appear to sensitize glioma cells to the cytotoxic effects of PX-866 using ...YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
... into a randomized Phase III study evaluating nimotuzumab in adult glioma patients and into a randomized Phase IIb/IIIa trial in patients ... to enroll children with progressive, diffuse, intrinsic pontine glioma (DIPG) into a Phase II trial at multiple sites in the US, Canada ...YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
... in a randomized Phase III study evaluating nimotuzumab in adult glioma patients and a randomized Phase IIb/IIIa trial in patients with ... to enroll children with progressive, diffuse, intrinsic pontine glioma (DIPG) into a Phase II trial at multiple sites in the US, Canada ...YM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG
... to the clinical program being undertaken globally for this promising drug. Recruitment of our Phase III trial in newly diagnosed pediatric pontine glioma has been concluded and we anticipate that recruitment in our randomised Phase III trial in adult glioblastoma grade IV will be completed in 2009. We ...Telik Reports Preclinical Results at AACR Annual Meeting
... orally and parenterally against a wide variety of human tumor types, including breast, pancreatic, prostate, and colorectal carcinomas, as well as glioma and promyelocytic leukemia. Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering ...YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE
... this molecule to be best-in-class in an established area of cancer therapy. It is currently undergoing a YM sponsored confirmatory trial in pediatric glioma in Canada and the US while being advanced in several Phase II and III trials by YM's licensees and other companies advancing the drug ....Is Earlier Detection of Cancers Such as Glioma Possible?
... of cancer. This test was first used to aid in the diagnosis of brain cancer, and was then found to be applicable to other common cancers because the glioma peptide contains a structural characteristic that is shared by other malignant cells. After early detection of cancers with the aid of the AMAS ...